Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daylight-PDT for AK: BF-200 ALA vs MAL
NCT01893203Phase 4Completed
- Sponsor
- Päijät-Häme Wellbeing Services County
- Start
- Aug 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aminolevulinic acid 10% gel in actinic keratosis (AK), sponsored by Päijät-Häme Wellbeing Services County. Started Aug 2013; status: completed.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01893203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01893203.